BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

BENDER ROBERT & ASSOCIATES's Holding History (CIK: 0000894300)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 23,710 Value ($000) $180 Avg Close $8.33 Range $7.42 - $9.23
Q2 2025
Shares 23,710 Value ($000) $212 Avg Close $9.31 Range $6.02 - $11.31
Q4 2024
Shares 23,710 Value ($000) $178 Avg Close $7.59 Range $6.85 - $8.44
Q4 2023
Shares 56,600 Value ($000) $339 Avg Close $5.79 Range $4.83 - $7.06
Q3 2023
Shares 56,600 Value ($000) $401 Avg Close $7.18 Range $6.62 - $7.95
Q2 2023
Shares 68,600 Value ($000) $483 Avg Close $8.02 Range $6.87 - $9.07
Q1 2023
Shares 68,600 Value ($000) $572 Avg Close $9.63 Range $7.82 - $12.08
Q3 2022
Shares 68,600 Value ($000) $864 Avg Close $12.87 Range $10.33 - $15.43
Q2 2022
Shares 68,600 Value ($000) $726 Avg Close $10.32 Range $7.61 - $18.00